Home Cart 0 Sign in  

[ CAS No. 1975-51-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1975-51-5
Chemical Structure| 1975-51-5
Structure of 1975-51-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1975-51-5 ]

Related Doc. of [ 1975-51-5 ]

Alternatived Products of [ 1975-51-5 ]

Product Details of [ 1975-51-5 ]

CAS No. :1975-51-5 MDL No. :MFCD00210697
Formula : C8H7NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :XXXOBNJIIZQSPT-UHFFFAOYSA-N
M.W : 181.15 Pubchem ID :74790
Synonyms :

Calculated chemistry of [ 1975-51-5 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.19
TPSA : 83.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.23 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.06
Log Po/w (XLOGP3) : 1.65
Log Po/w (WLOGP) : 1.6
Log Po/w (MLOGP) : 0.84
Log Po/w (SILICOS-IT) : -0.47
Consensus Log Po/w : 0.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.21
Solubility : 1.11 mg/ml ; 0.00614 mol/l
Class : Soluble
Log S (Ali) : -3.01
Solubility : 0.177 mg/ml ; 0.00098 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.54
Solubility : 5.24 mg/ml ; 0.0289 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.59

Safety of [ 1975-51-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1975-51-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1975-51-5 ]
  • Downstream synthetic route of [ 1975-51-5 ]

[ 1975-51-5 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 1975-51-5 ]
  • [ 74-88-4 ]
  • [ 62621-09-4 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; Method L:Step a: [00293] A mixture of 2-methyl-4-nitrobenzoic acid (l eq.) iodomethane (1.1 eq.), K2CO3 (1.5 eq.), and 10 mL of DMF is stirred for 2hrs at room temperature, then poured into water and extracted with AcOEt. The extract is washed with water and brine, dried over anhydrous MgSψ4, and evaporated to afford the expected compound in quantative yield.
89% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 3 h; A solution of 2-methyl-4-nitro-benzoic acid (10 g, 55 mmol), MeI (3.8 ml, 61 mmol) and K2CO3 (11.4 g, 83 mmol) in DMF was stirred for 3 h at RT after which the reaction was poured onto water and extracted in EtOAc. The organic fractions were washed with water and brine, dried over Na2SO4 and concentrated to give the desired product as an orange solid (9.57g, 89percent). 1H NMR (400 MHz, DMSO-^6) δ ppm 2.60 (s, 3 H), 3.88 (s, 3 H), 8.00 (d, J=8.70 Hz, 1 H), 8.10 - 8.16 (m, 1 H), 8.21 (d, J=2.29 Hz, I H).
Reference: [1] Patent: WO2010/10184, 2010, A1, . Location in patent: Page/Page column 59
[2] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 22, p. 7625 - 7651
[3] Patent: WO2009/122180, 2009, A1, . Location in patent: Page/Page column 101
[4] Patent: WO2015/81891, 2015, A1, . Location in patent: Page/Page column 138
  • 2
  • [ 67-56-1 ]
  • [ 1975-51-5 ]
  • [ 62621-09-4 ]
YieldReaction ConditionsOperation in experiment
100% at 70℃; for 18 h; Intermediate 5; Methyl 2-methyl-4-nitrobenzoate; SOCI2 was added to a solution of 2-methyl-4-nitrobenzoic acid (3 g, 16.5 mmol) in methanol dropwise. The reaction mixture was stirred at 70°C for 18 hours. The mixture was evaporated and the residue was diluted with diethyl ether, washed with water and NaOH 1 N. The organic phase was dried over Na2SO4, filtered and evaporated to give the title compound as dark yellow solid (3.25 g, quantitative yield). NMR1H NMR (300 MHz), CDCI3 δ: 7.95 (m, 3H), 3.86 (s, 3H), 2.59 (s, 3H).
98% at 70℃; for 7 h; Under ice bath was added SOCl2 dropwise anhydrous methanol (100ml) in. And then a solution of 2-methyl-4-nitrobenzoic acid (10.0 g, 55.2 mmol) in anhydrous methanol (70mL) solution, 1 hour addition was complete. This mixed system placed in an oil bath at 70 ° C 7 hours, TLC the reaction was complete. Cooling, the solvent was distilled off under reduced pressure. The residue was dissolved in ethyl acetate (100 mL) was added saturated sodium bicarbonate (100 mL), separated, the aqueous phase was extracted once with ethyl acetate (50mL). The combined organic phase was dried over anhydrous magnesium sulfate, filtered, and the solvent was distilled off under reduced pressure, and dried under high vacuum to give a white solid 10.5g, 98percent yield
96% for 15 h; Reflux Example 1) l-MethyI-lH-imidazole-4-suIfonic acid (4-chloro-benzyI)-(2-ethyI-l- oxo-2,3-dihydro-lH-isoindol-5-yl)-amide (Method A)i) 2-Methyl-4-nitro-benzoic acid methyl ester2-Methyl-4-nitrobenzoic acid (2.00 g, 11.00 mmol) was stirred in concentrated sulfuric acid (0.6 ml) and methanol (25 ml) at reflux for 15 hrs. Reaction was cooled and the solvent evaporated. The resulting residue was partitioned between water and dichloromethane and the organic phase separated. The aqueous phase was extracted with dichloromethane (x3) and the combined organics washed with brine, then dried (MgSO4) and evaporated in vacuo to yield the title compound as a pale yellow solid (1.89 g, 96percent). HPLC retention time 4.39min.
95.3% at 0 - 70℃; for 24.5 h; Step 1:
Synthesis of 2-Methyl-4-nitro-benzoic acid methyl ester
To a solution of 2-methyl-4-nitro-benzoic acid (3 g, 16.56 mmole) in 30 ml methanol was added at 0° C. sulfuric acid (95-98percent, 10 ml) slowly for ½ hr.
The reaction mixture was stirred at 70° C. for 24 hrs.
Mixture was cooled down, a solid precipitated out, then the mixture was concentrated, diluted with 50 ml water, stirred for 10 minutes, filtered off, the solid was washed with water, dried to afford 3.08 g of brown solid, 95.3percent yield, pure by H NMR.
94.65% for 15 h; Reflux In a 250 mL, 3-neck round-bottomed flask, 2-methyl-4-nitrobenzoic acid (20 g, 93.8 mmol) was charged with methanol (100 mL) and sulfuric acid (4 mL). The reaction mixture was refluxed for 15 h. After completion, the reaction mixture was concentrated to obtain the crude product which was added water (200 mL) and basified to pH 7-8 with aqueous NaHC03 solution. Aqueous solution was extracted with dichloromethane (250 mL X 3), the organic layer was washed with saturated brine solution followed by drying over anhydrous sodium sulphate. The solvent was removed to obtain methyl 2-methyl-4- nitrobenzoate 1), 20 g; Yield: 94.65percent.
93% at 0 - 80℃; for 2 h; SOCl2 (2.6 g, 22.0 mmol) was slowly added to the solution of 2-methyl-4- nitrobenzoic acid (61.1) (2.0 g, 11.0 mmol) in MeOH (20 mL) at 0 °C. The resulting mixture was heated at 80 °C for 2 h. After cooling to room temperature, the reaction mixture was concentrated to afford methyl 2-methyl-4-nitrobenzoate (61.2) as a yellow oil (2.0 g, 93percent).
91.3% at 12 - 20℃; for 12 h; Thionyl chloride (4.3 g, 36.45 mmol) was added dropwise to a stirred solution of 18 (3 g, 16.57 mmol) in MeOH (25 mL) while maintaining the internal temperature below 12 °C. When the addition was complete the mixture was left to stand at room temperature for 12 h to result a white precipitation. The mixture was filtered and the filtrate was concentrated under reduced pressure to afford white solid. The solid was washed with hexane and ethyl ether to afford 19 (2.95 g, 91.3percent); mp 153.7-154.4 °C (lit.39 mp 153-154 °C); Rf 0.43 (hexane/EtOAc 3:1); 1H NMR (CDCl3) δ 2.69 (s, 3H, CH3), 3.95 (s, 3H, COOCH3), 8.02-8.11 (m, 3H, C6H3).
90.9% at 20 - 60℃; EXAMPLE 75
2-Methyl-4-nitro-benzoic acid methyl ester (1)
In accordance with general method S, 5.00 g (27.60 mmol) of 2-methyl-4-nitro-benzoic acid are dissolved in 20 ml of methanol, with heating, and 6 ml of concentrated sulfuric acid are added.
The mixture is refluxed for 5 h. Yield: 4.90 g (90.9percent); melting point: 73.6° C.
C9H9NO3(Mr=195.18); GC (method 1) 9.55 min
1H-NMR (CDCl3) in ppm: 8.19-8.09 (m, 2H, aryl H), 7.99 (d, 1H, J=8.52 Hz, aryl H), 3.87 (s, 3H, -OCH3), 2.59 (s, 3H, -CH3)
13C-NMR (CDCl3) in ppm: 166.35 (-C=O), 159.29 (C4), 141.79 (C2), 135.14 (C1), 131.43 (C6), 126.06 (C3), 120.48 (C5), 52.37 (-OCH3), 21.50 (-CH3)
IR (ATR) (cm-1): 1722, 1523, 1432, 1348, 1260, 1081, 896, 821, 786, 730
MS m/z (percent): 195 (70), 164 (100), 134 (21), 118 (29), 63 (15). General Method SFor esterification of the acid group of the starting compound 2-methyl-4-nitro-benzoic acid, the stated amount is dissolved in methanol in a 100 ml one-necked flask at room temperature, concentrated H2SO4 is added and the mixture is refluxed at approx. 60° C. for 6 h. The excess alcohol is removed in vacuo, the residue is taken up in EtOAc and the mixture is deacidified repeatedly with 20percent strength sodium hydroxide solution. After drying (Na2SO4), the combined organic phases are concentrated in vacuo.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 3, p. 942 - 945
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 3, p. 946 - 949
[3] Patent: WO2009/47240, 2009, A1, . Location in patent: Page/Page column 28
[4] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3510 - 3519
[5] Patent: CN103804358, 2016, B, . Location in patent: Paragraph 0117
[6] Patent: WO2010/139953, 2010, A1, . Location in patent: Page/Page column 31-32
[7] Patent: US9138427, 2015, B2, . Location in patent: Page/Page column 286
[8] Patent: WO2016/81464, 2016, A1, . Location in patent: Paragraph 00117
[9] Patent: WO2016/90079, 2016, A1, . Location in patent: Paragraph 00866
[10] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 11, p. 3585 - 3594
[11] Patent: US2012/115862, 2012, A1, . Location in patent: Page/Page column 34-35
[12] Patent: WO2005/80388, 2005, A1, . Location in patent: Page/Page column 63
[13] Patent: WO2006/17443, 2006, A2, . Location in patent: Page/Page column 155-156
[14] Patent: US2010/15141, 2010, A1, . Location in patent: Page/Page column 26
[15] Patent: WO2011/19538, 2011, A1, . Location in patent: Page/Page column 127
[16] Patent: CN105218397, 2016, A, . Location in patent: Paragraph 0011
  • 3
  • [ 1975-51-5 ]
  • [ 62621-09-4 ]
Reference: [1] Patent: WO2013/184734, 2013, A1,
[2] Patent: WO2014/201073, 2014, A1,
  • 4
  • [ 1975-51-5 ]
  • [ 72005-84-6 ]
Reference: [1] Patent: US2013/310394, 2013, A1,
  • 5
  • [ 99-51-4 ]
  • [ 1975-51-5 ]
YieldReaction ConditionsOperation in experiment
72% for 12 h; Reflux Preparation of 2-methyl-4-nitrobenzoic acid4-Nitro-o-xylene (0.15 g, 1 mmol), NHPI (0.05 g,0.3 mmol), nitric acid (40 percent; 1.26 g, 8 mmol),CoCl2 ·6H2O (7.1 mg, 0.03 mmol), Mn(OAc)2 ·4H2O(7.1 mg, 0.03 mmol) and a phase transfer catalyst(0.04 mmol) were added to a 50 mL three-neckedround bottomed flask equipped with a magnetic stirrerand a reflux condenser. The mixture was heated underreflux for 12 h at normal pressure. After the reactioncompletion the mixture was cooled to room temperatureand washed with 10 mL of water. The aqueousphase was extracted with ethyl acetate (3 × 5 mL)and the obtained organic phase was dried with anhydroussodium sulfate. Ethyl acetate was removedfrom the organic layer by rotary evaporation and thecrude products were determined by the HPLC analysisbased on the internal standard (2,4-dinitrotoluene).The crude products were re-crystallized (EtOH/H2Or = 3 : 1) to give pure 2-methyl-4-nitrobenzoic acid(0.13 g, 72 percent) in form of white needle crystals; m.p.:151–152C. IR, ν/cm−1, (KBr): 1702 cm−1.1H NMR(CDCl3, 500 MHz), δ: 2.79 (s, 3H, CH3 ), 8.13–8.17(m, 2H, Ar), 8.21 (d, 1H, J = 6.8 Hz, Ar). Anotherproduct is the 4-nitrophthalic acid which is separatedby column chromatography from ethyl acetate/hexane(r = 1 : 5) in form of light colored needle crystals;m.p.:163C. IR, ν/cm−1, (KBr): 1730 cm−1,1670 cm−1. 1H NMR (CDCl3, 500 MHz), δ: 7.86 (d,J = 8.6 Hz, 1H, Ar), 8.36 (dd, J1 = 8.6Hz, J2 = 2.0Hz,1H, Ar), 8.42 (d, J = 2.0 Hz, 1H, Ar) (Huntress et al.,1936).
62% With oxygen; sodium hydroxide In methanol; water at 65℃; for 24 h; Autoclave 3,4-dimethyl-1-nitrobenzene (907 mg, 6 mmol, 1.0 eq)Sodium hydroxide (1.8 g, 45 mmol, 7.5 eq)Was added to a 100 ml autoclave,Add 10 ml of 50percent (v / v) methanol (5 ml of methanol, 5 ml of water)After charging oxygen three times,Passing oxygen gas (pressure 1.8MPa),In the oil bath temperature control 65 for 24 hoursAfter the reaction was diluted with methanol,Neutral and PH = 2-3,The solvent was removed under reduced pressure,After the addition of ethyl acetate,filter.Separated by chromatography,3,4-dimethyl-1-nitrobenzene recovered 72mg (0.47mmol),1,2-dimethyl-4-nitrobenzene conversion was 92percentTo give 673 mg (3.72 mmol) of 2-methyl-4-nitrobenzoic acid,The yield was 62percent.
Reference: [1] Chemical Papers, 2015, vol. 69, # 4, p. 580 - 585
[2] Patent: CN106995374, 2017, A, . Location in patent: Paragraph 0043; 0044; 0045; 0046; 0047; 0048; 0049-0057
[3] Journal of Organic Chemistry, 2018, vol. 83, # 15, p. 8092 - 8103
[4] Patent: CN105777565, 2016, A, . Location in patent: Paragraph 0006
  • 6
  • [ 99584-16-4 ]
  • [ 1975-51-5 ]
YieldReaction ConditionsOperation in experiment
89.5% With hydrogenchloride In water for 20 h; Heating / reflux A stirred mixture of 2-methyl-4-nitrobenzamide and 6N HC1 (1.3 L) was refluxed for 20 hours, then cooled. The resulting solid was filtered, washed with cold water, and dried on a lyophilizer to obtain the title compound as a solid. Yield: 160 g (Overall yield of last two steps was 89.50percent), Melting Point: 149- 150#x0;C.
Reference: [1] Patent: WO2004/69245, 2004, A1, . Location in patent: Page/Page column 110
[2] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3510 - 3519
[3] Bulletin de la Societe Scientifique de Bretagne, 1956, vol. 31, p. Sonderheft S.9,41
  • 7
  • [ 89001-53-6 ]
  • [ 1975-51-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1998, vol. 6, # 3, p. 271 - 282
[2] Chemische Berichte, 1919, vol. 52, p. 1083
[3] Journal fuer Praktische Chemie (Leipzig), 1915, vol. <2> 92, p. 145
[4] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3510 - 3519
[5] Patent: WO2005/80388, 2005, A1, . Location in patent: Page/Page column 62-63
[6] Patent: WO2005/51366, 2005, A2, . Location in patent: Page/Page column 78
[7] Patent: WO2005/51366, 2005, A2, . Location in patent: Page/Page column 78
  • 8
  • [ 6277-17-4 ]
  • [ 1975-51-5 ]
Reference: [1] Patent: US5968942, 1999, A,
[2] Patent: US6046190, 2000, A,
[3] Patent: US6060476, 2000, A,
  • 9
  • [ 2486-75-1 ]
  • [ 1975-51-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2006, vol. 45, # 47, p. 8016 - 8018
  • 10
  • [ 99-52-5 ]
  • [ 1975-51-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3510 - 3519
[2] Patent: CN105218375, 2016, A,
  • 11
  • [ 108-88-3 ]
  • [ 1975-51-5 ]
Reference: [1] Patent: CN105218375, 2016, A,
  • 12
  • [ 22162-16-9 ]
  • [ 1975-51-5 ]
Reference: [1] Die Pharmazie, 1969, vol. 24, # 1, p. 29 - 32
  • 13
  • [ 619-15-8 ]
  • [ 1975-51-5 ]
Reference: [1] Patent: CN105218375, 2016, A,
  • 14
  • [ 95-47-6 ]
  • [ 1975-51-5 ]
Reference: [1] Patent: CN105777565, 2016, A,
  • 15
  • [ 89001-53-6 ]
  • [ 1975-51-5 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1915, vol. <2> 92, p. 149
  • 16
  • [ 99-51-4 ]
  • [ 7697-37-2 ]
  • [ 1975-51-5 ]
  • [ 1975-52-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 161
  • 17
  • [ 7647-01-0 ]
  • [ 89001-53-6 ]
  • [ 64-19-7 ]
  • [ 1975-51-5 ]
Reference: [1] Chemische Berichte, 1919, vol. 52, p. 1083
  • 18
  • [ 99-51-4 ]
  • [ 7697-37-2 ]
  • [ 1975-51-5 ]
  • [ 1975-52-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 161
  • 19
  • [ 1975-51-5 ]
  • [ 578-39-2 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 161
  • 20
  • [ 1975-51-5 ]
  • [ 2486-75-1 ]
YieldReaction ConditionsOperation in experiment
98% With 5%-palladium/activated carbon; hydrogen In ethanolFlow reactor General procedure: Before each run, the system (see Fig.4) was allowed to equilibrate by pumping solvent through for 30min with the Tube-in-Tube device at 16bar of hydrogen. An omnifit cartridge (20.0mm OD, 15.0mm ID) containing 1g of Pd-C catalyst was used. To avoid an overpressure of the system in the event of blockage, the upper pressure cut-off limit on the Knauer pump was set to 25bar. With the injection loop disconnected from the flow line, the loop was opened and filled manually (using a syringe) with 3.6mL of a 0.076M solution of starting material in ethanol (excess starting material solution exiting the loop was recovered for reuse). The injection loop was then closed off and switched into the flow stream. The outlet from the system (downstream of the back-pressure regulator) was collected for 120min. The solvent was removed under reduced pressure (using a rotary evaporator followed by a 2-stage rotary vane pump) to afford the product.
Reference: [1] Tetrahedron, 2018, vol. 74, # 47, p. 6795 - 6803
[2] Chemische Berichte, 1884, vol. 17, p. 161
[3] Patent: US2012/46467, 2012, A1, . Location in patent: Page/Page column 26
  • 21
  • [ 1975-51-5 ]
  • [ 133446-99-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 22, p. 7625 - 7651
[2] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3510 - 3519
[3] Patent: WO2011/19538, 2011, A1,
[4] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 11, p. 3585 - 3594
[5] Patent: US2012/115862, 2012, A1,
[6] Patent: WO2015/81891, 2015, A1,
[7] Patent: US9138427, 2015, B2,
[8] Patent: WO2016/81464, 2016, A1,
[9] Patent: WO2016/90079, 2016, A1,
[10] Patent: CN103804358, 2016, B,
[11] Patent: WO2009/122180, 2009, A1,
  • 22
  • [ 1975-51-5 ]
  • [ 110568-64-4 ]
Reference: [1] Patent: WO2011/19538, 2011, A1,
[2] Patent: WO2015/81891, 2015, A1,
[3] Patent: US9138427, 2015, B2,
[4] Patent: CN103804358, 2016, B,
  • 23
  • [ 1975-51-5 ]
  • [ 150683-30-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 8, p. 1743 - 1754
  • 24
  • [ 1975-51-5 ]
  • [ 137973-76-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 8, p. 1743 - 1754
  • 25
  • [ 1975-51-5 ]
  • [ 222036-66-0 ]
Reference: [1] Patent: WO2011/19538, 2011, A1,
[2] Patent: WO2015/81891, 2015, A1,
[3] Patent: US9138427, 2015, B2,
[4] Patent: CN103804358, 2016, B,
  • 26
  • [ 1975-51-5 ]
  • [ 672293-33-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 11, p. 3349 - 3353
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1975-51-5 ]

Aryls

Chemical Structure| 6954-70-7

[ 6954-70-7 ]

2,5-Dimethyl-4-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3807-81-6

[ 3807-81-6 ]

5-Nitrobenzene-1,2,3-tricarboxylic acid

Similarity: 0.98

Chemical Structure| 220504-75-6

[ 220504-75-6 ]

2,4-Dimethyl-5-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3898-66-6

[ 3898-66-6 ]

2-(Carboxymethyl)-5-nitrobenzoic acid

Similarity: 0.97

Chemical Structure| 39585-32-5

[ 39585-32-5 ]

2-(Carboxymethyl)-4-nitrobenzoic acid

Similarity: 0.97

Carboxylic Acids

Chemical Structure| 6954-70-7

[ 6954-70-7 ]

2,5-Dimethyl-4-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3807-81-6

[ 3807-81-6 ]

5-Nitrobenzene-1,2,3-tricarboxylic acid

Similarity: 0.98

Chemical Structure| 220504-75-6

[ 220504-75-6 ]

2,4-Dimethyl-5-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 39585-32-5

[ 39585-32-5 ]

2-(Carboxymethyl)-4-nitrobenzoic acid

Similarity: 0.97

Chemical Structure| 20246-81-5

[ 20246-81-5 ]

4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid

Similarity: 0.95

Nitroes

Chemical Structure| 6954-70-7

[ 6954-70-7 ]

2,5-Dimethyl-4-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 3807-81-6

[ 3807-81-6 ]

5-Nitrobenzene-1,2,3-tricarboxylic acid

Similarity: 0.98

Chemical Structure| 220504-75-6

[ 220504-75-6 ]

2,4-Dimethyl-5-nitrobenzoic acid

Similarity: 0.98

Chemical Structure| 39585-32-5

[ 39585-32-5 ]

2-(Carboxymethyl)-4-nitrobenzoic acid

Similarity: 0.97

Chemical Structure| 20246-81-5

[ 20246-81-5 ]

4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid

Similarity: 0.95